Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Accenture
Citi
Mallinckrodt
Express Scripts
McKesson
McKinsey
AstraZeneca

Generated: September 19, 2018

DrugPatentWatch Database Preview

Carvedilol phosphate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for carvedilol phosphate and what is the scope of carvedilol phosphate freedom to operate?

Carvedilol phosphate is the generic ingredient in two branded drugs marketed by Impax Labs Inc, Sun Pharm Industries, and Smithkline Beecham, and is included in three NDAs. There are two patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for carvedilol phosphate. Five suppliers are listed for this compound.

Synonyms for carvedilol phosphate
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol
(+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol
(2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol phosphate salt (1:1)
(2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol phosphate salt (1:1) hemihydrate
(2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol phosphate salt (1:1) hemihydrate
[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine
1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol
1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol
1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; phosphoric acid; hydrate
1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol
1-9H-(Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol phosphate hemihydrate
102641-EP2270011A1
102641-EP2272841A1
102641-EP2275420A1
102641-EP2298764A1
102641-EP2298765A1
102641-EP2301936A1
107741-96-8
1196658-85-1
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)-
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, phosphate (1:1)
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, phosphate (salt), hydrate (2:2:1)
2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, phosphate, hydrate (1:1:1)
309C892
374779-45-0
610309-89-2
72956-09-3
956C093
AB0008431
AB00639903_10
AB00639903_11
AB00639903_12
AB00639903-07
AB00639903-09
AB1004830
AC-1641
AC1L1E0B
AK163147
AKOS005554967
AKOS026749869
AN-14749
AN-27765
API0001873
Artist
Artist (TN)
Atlana Pharma brand of carvedilol
AX8120145
BBL029064
BC204100
BCP0726000253
BCP9000493
BDBM25759
BG0129
Bio-0014
BIS(1-(9H-CARBAZOL-4-YLOXY)-3-{[2-(2-METHOXYPHENOXY)ETHYL]AMINO}PROPAN-2-OL) BIS(PHOSPHORIC ACID) HYDRATE
BM 14,190
BM 14.190
BM 14190
BM-14-190
BM-14.190
BM-14190
BRD-A10977446-001-04-8
BRD-A10977446-045-01-1
C-21835
C06875
C24H26N2O4
C24H31N2O9P
Carloc
Carloc (TN)
carvedilol
Carvedilol (JAN/USAN/INN)
Carvedilol (phosphate hemihydrate)
Carvedilol [USAN:INN:BAN:JAN]
Carvedilol [USAN:USP:INN:BAN:JAN]
Carvedilol 1.0 mg/ml in Methanol
Carvedilol dihydrogen phosphate hemihydrate
Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard
carvedilol HCl
Carvedilol hydrochloride
Carvedilol phosphate (USAN)
Carvedilol phosphate [USAN]
Carvedilol phosphate anhydrous
Carvedilol phosphate hemihydrate
Carvedilol phosphate hydrate (JAN)
Carvedilol phosphate monohydrate
carvedilol, (+-)-isomer
carvedilol, (R)-isomer
carvedilol, (S)-isomer
Carvedilol, >=98% (HPLC), solid
carvedilol, 14C-labeled
Carvedilol, European Pharmacopoeia (EP) Reference Standard
Carvedilol, pharmaceutical secondary standard; traceable to USP and PhEur
Carvedilol, United States Pharmacopeia (USP) Reference Standard
Carvedilolum
Carvedilolum [Latin]
carvediol
CC-25436
CCG-100917
CCG-207952
CCG-213312
CHEBI:3441
CHEMBL1201167
CHEMBL723
Coreg
Coreg (TN)
Coreg CR
Coreg CR (TN)
Coropres
Coropress
CPD000449280
CS-1194
CTK3J2232
D00255
D03415
D0W9LX
DB01136
Dibloc
Dilatrend
Dilatrend (TN)
DQ 2466
DQ-2466
DTXSID8022747
EG-P042
Eucardic
Eucardic (TN)
FT-0603059
FT-0652640
GlaxoSmithKline brand of carvedilol
GTPL551
HMS2051N03
HMS2089B09
HMS2093E12
HMS3261E15
HMS3269N11
HMS3393N03
HMS3655O14
HSDB 7044
HY-B0006
I06-0064
I06-1477
J10039
JAYBFQXVKDGMFT-UHFFFAOYSA-N
KB-75594
KBio2_002145
KBio2_004713
KBio2_007281
KBio3_002323
KBioGR_001252
KBioSS_002145
Kredex
KS-00000XRT
KS-1037
KSC492E3F
L001243
Lakeside brand of carvedilol
LHNYXTULDSJZRB-UHFFFAOYSA-N
LP00347
LS-121875
LS-186601
MCULE-7944987271
MFCD00864692
MLS000758299
MLS000759508
MLS001424092
MLS006011886
MolPort-003-666-814
NC00167
NCGC00167832-01
NCGC00167832-02
NCGC00167832-03
NCGC00167832-04
NCGC00261032-01
NSC-751177
NSC-758694
NSC751177
NSC758694
OGHNVEJMJSYVRP-UHFFFAOYSA-N
Pharmakon1600-01504257
PL008198
PL039781
PL061817
PL068260
PubChem18218
Q-200801
Querto
Roche brand of carvedilol
RTR-037608
s1831
SAM001246736
SAM001247021
SBI-0206771.P001
SC-13445
SCHEMBL10082334
SCHEMBL13287211
SCHEMBL194220
SCHEMBL22293
SCHEMBL599530
SK&F-105517
SK&F-105517-D
SKF 105517
SKF 105517D
SMR000449280
SPBio_001885
Spectrum_001665
Spectrum2_001673
Spectrum3_001182
Spectrum4_000636
Spectrum5_001436
SR-01000759289
SR-01000759289-9
ST24036957
STK621453
TL8005080
Tox21_500347
TR-037608
W-5131
W0023
Z2786051695

US Patents and Regulatory Information for carvedilol phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Impax Labs Inc CARVEDILOL PHOSPHATE carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 204717-002 May 7, 2018 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-003 Oct 20, 2006 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 AB RX Yes No ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for carvedilol phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 ➤ Sign Up ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-002 Oct 20, 2006 ➤ Sign Up ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-004 Oct 20, 2006 ➤ Sign Up ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-001 Oct 20, 2006 ➤ Sign Up ➤ Sign Up
Smithkline Beecham COREG CR carvedilol phosphate CAPSULE, EXTENDED RELEASE;ORAL 022012-001 Oct 20, 2006 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
Accenture
Citi
Mallinckrodt
Express Scripts
McKesson
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.